Lab-Grown tumor models could personalize mesothelioma care
NCT ID NCT07330271
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new way to choose cancer treatments for people with peritoneal mesothelioma. After surgery, doctors will grow a model of the patient's tumor in the lab and test different drugs on it to find the best match. The goal is to see if this personalized approach helps patients live longer without their cancer growing, compared to standard chemotherapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL MESOTHELIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tsinghua University affiliated Beijing Tsinghua Changgung Hospital
RECRUITINGBeijing, 102218, China
Contact Phone: •••-•••-•••• Email: •••••@•••••